289 related articles for article (PubMed ID: 18401830)
1. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
[TBL] [Abstract][Full Text] [Related]
2. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
3. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
4. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
7. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
[TBL] [Abstract][Full Text] [Related]
8. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
10. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
12. c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
Nadella K; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Oct; 27(10):591-599. PubMed ID: 32738126
[TBL] [Abstract][Full Text] [Related]
13. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
14. mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).
de Joussineau C; Sahut-Barnola I; Tissier F; Dumontet T; Drelon C; Batisse-Lignier M; Tauveron I; Pointud JC; Lefrançois-Martinez AM; Stratakis CA; Bertherat J; Val P; Martinez A
Hum Mol Genet; 2014 Oct; 23(20):5418-28. PubMed ID: 24865460
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos S; Robinson-White A; Lenherr S; Weinberg FD; Claflin E; Meoli E; Cho-Chung YS; Stratakis CA
Cancer Res; 2004 Dec; 64(24):8811-5. PubMed ID: 15604237
[TBL] [Abstract][Full Text] [Related]
16. PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.
Bram Z; Louiset E; Ragazzon B; Renouf S; Wils J; Duparc C; Boutelet I; Rizk-Rabin M; Libé R; Young J; Carson D; Vantyghem MC; Szarek E; Martinez A; Stratakis CA; Bertherat J; Lefebvre H
JCI Insight; 2016 Sep; 1(15):e87958. PubMed ID: 27699247
[TBL] [Abstract][Full Text] [Related]
17. Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation.
Horvath A; Mathyakina L; Vong Q; Baxendale V; Pang AL; Chan WY; Stratakis CA
J Clin Endocrinol Metab; 2006 Feb; 91(2):584-96. PubMed ID: 16278264
[TBL] [Abstract][Full Text] [Related]
18. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
Louiset E; Stratakis CA; Perraudin V; Griffin KJ; Libé R; Cabrol S; Fève B; Young J; Groussin L; Bertherat J; Lefebvre H
J Clin Endocrinol Metab; 2009 Jul; 94(7):2406-13. PubMed ID: 19383776
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
